Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flonase DTC Ads Highlight Formulary Status Versus Antihistamines

Executive Summary

GlaxoSmithKline's direct-to-consumer ads for Flonase emphasize that "99% of prescription plans" cover the allergy nasal spray
Advertisement

Related Content

Allegra DTC Ads Include Comparative Claims Against Zyrtec, OTCs
Allegra DTC Ads Include Comparative Claims Against Zyrtec, OTCs
Flonase, Zaditor DTC Ads Cited By FDA; Both Allergy Campaigns Are Over
Flonase, Zaditor DTC Ads Cited By FDA; Both Allergy Campaigns Are Over
Merck Singulair Formulary Status Stable; Restricted Use In Subset Of Plans
Merck Singulair Formulary Status Stable; Restricted Use In Subset Of Plans
FDA First Amendment Plan: Series Of Guidances Rather Than Omnibus Rule
FDA First Amendment Plan: Series Of Guidances Rather Than Omnibus Rule
Merck Singulair Presents Managed Care Test: Covering Asthma, Not Allergies
Merck Singulair Presents Managed Care Test: Covering Asthma, Not Allergies
Advertisement
UsernamePublicRestriction

Register

PS041433

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel